Enlight (NASDAQ: ENLT) director sells 25,538 shares after exercising options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Enlight Renewable Energy Ltd. director and vice chairman Yair Seroussi exercised stock options and sold shares in early May 2026. He exercised 35,000 ordinary shares at $23.22 per share, with 9,462 shares delivered back to the company to cover the exercise price and tax obligations. He then made open-market sales totaling 25,538 shares at prices of $90.63 and $89.04 per share, and reported direct ownership of 14,233 ordinary shares afterward, alongside remaining stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 25,538 shares ($2,309,686)
Net Sell
10 txns
Insider
SEROUSSI YAIR
Role
null
Sold
25,538 shs ($2.31M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) | 4,256 | $0.00 | -- |
| Exercise | Ordinary shares, NIS 0.1 par value per share | 4,256 | $23.22 | $99K |
| Tax Withholding | Ordinary shares, NIS 0.1 par value per share | 1,223 | $89.04 | $109K |
| Sale | Ordinary shares, NIS 0.1 par value per share | 3,033 | $89.04 | $270K |
| Exercise | Stock Options (right to buy) | 30,744 | $0.00 | -- |
| Exercise | Ordinary shares, NIS 0.1 par value per share | 30,744 | $23.22 | $714K |
| Tax Withholding | Ordinary shares, NIS 0.1 par value per share | 8,239 | $90.63 | $747K |
| Sale | Ordinary shares, NIS 0.1 par value per share | 22,505 | $90.63 | $2.04M |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (right to buy) — 36,000 shares (Direct, null);
Ordinary shares, NIS 0.1 par value per share — 18,489 shares (Direct, null)
Footnotes (1)
- Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price. Represents a transaction price of NIS 263.11, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.903 as of the date immediately preceding the date of the transaction. Represents a transaction price of NIS 258.85, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction. Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.
Key Figures
Shares sold: 25,538 shares
Sale prices: $90.63 and $89.04 per share
Options exercised: 35,000 shares at $23.22
+4 more
7 metrics
Shares sold
25,538 shares
Open-market sales of ordinary shares in May 2026
Sale prices
$90.63 and $89.04 per share
Ordinary share sale prices on May 7 and May 8, 2026
Options exercised
35,000 shares at $23.22
Ordinary shares acquired via option exercises coded M
Tax/exercise share delivery
9,462 shares
Shares delivered to company for exercise price and tax
Shares owned after
14,233 shares
Direct ordinary-share holdings following reported transactions
Remaining options (zero price)
11,339 underlying shares
Stock options with $0.00 exercise price, direct holdings
Remaining options ($27.33)
51,574 underlying shares
Stock options at $27.33 exercise price expiring 2032-10-01
Key Terms
restricted share units, Performance-based RSUs ("PSUs"), Adjusted EBITDA, Bank of Israel representative exchange rate, +1 more
5 terms
Performance-based RSUs ("PSUs") financial
"Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches..."
Adjusted EBITDA financial
"The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F)..."
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Bank of Israel representative exchange rate financial
"converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS..."
exercise price financial
"Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transactions did ENLT director Yair Seroussi report on this Form 4?
Yair Seroussi reported exercising 35,000 Enlight Renewable Energy ordinary-share options at $23.22 and selling 25,538 shares in open-market trades at $90.63 and $89.04. Some additional shares were delivered back to the company to cover option exercise price and related tax obligations.
How many ENLT options did Yair Seroussi exercise in this Form 4?
He exercised stock options covering 35,000 Enlight Renewable Energy ordinary shares at an exercise price of $23.22 per share. These derivative exercises converted existing option awards into ordinary shares before subsequent tax-withholding dispositions and partial open-market sales disclosed in the same Form 4 filing.
How were tax and exercise costs handled in Yair Seroussi’s ENLT option exercises?
The Form 4 shows dispositions coded as F, where 9,462 Enlight ordinary shares were delivered to the company. A footnote explains these shares were retained by the company in payment of the option exercise price and related tax liability, rather than sold in the open market.